REPORTS

Let’s Pullulate and Expand Your Business

Supportive Care in Oncology Market - Global Professional Analysis and Forecast to 2026

Oct 11, 2019  |  186 PAGES  |  REPORT CODE: CMM204911
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Supportive Care in Oncology market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.0% during the forecast period.

This report presents the market size and development trends by detailing the Supportive Care in Oncology market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Supportive Care in Oncology market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Supportive Care in Oncology industry and will help you to build a panoramic view of the industrial development.

Supportive Care in Oncology Market, By Type:

  • Opioid analgesics

  • Nonsteroidal erythropoietin stimulating agents

  • Anti-infective drugs

  • Anti-imflammatory drugs

  • Bisphosphonates

  • Monoclonal antibodies

  • Anti-emetics drugs

  • Granulocyte colony stimulating factor

Supportive Care in Oncology Market, By Application:

  • Lung cancer

  • Prostate cancer

  • Breast cancer

  • Ovarian cancer

  • Leukemia

  • Bladder cancer

  • Liver cancer

  • Melanoma

  • Others

Some of the leading players are as follows:

  • Amgen Inc.

  • APR Applied Pharma Science Research S.A.

  • Novartis Ag.

  • Hoffmann LA- Roche Ltd

  • Johnson & Johnson

  • Baxter International Inc

  • Teva Pharmaceuticals Industries Ltd

  • Fagron Group BV

  • Acacia Pharma Ltd.

  • Kyowa Hakko Kirin Co Ltd.

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Supportive Care in Oncology Market: Technology Type Analysis

  • 4.1 Supportive Care in Oncology Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Supportive Care in Oncology Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Opioid analgesics

    • 4.3.2 Nonsteroidal erythropoietin stimulating agents

    • 4.3.3 Anti-infective drugs

    • 4.3.4 Anti-imflammatory drugs

    • 4.3.5 Bisphosphonates

    • 4.3.6 Monoclonal antibodies

    • 4.3.7 Anti-emetics drugs

    • 4.3.8 Granulocyte colony stimulating factor

5 Supportive Care in Oncology Market: Product Analysis

  • 5.1 Supportive Care in Oncology Product Market Share Analysis, 2018 & 2026

  • 5.2 Supportive Care in Oncology Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Supportive Care in Oncology Market: Application Analysis

  • 6.1 Supportive Care in Oncology Application Market Share Analysis, 2018 & 2026

  • 6.2 Supportive Care in Oncology Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Lung cancer

    • 6.3.2 Prostate cancer

    • 6.3.3 Breast cancer

    • 6.3.4 Ovarian cancer

    • 6.3.5 Leukemia

    • 6.3.6 Bladder cancer

    • 6.3.7 Liver cancer

    • 6.3.8 Melanoma

    • 6.3.9 Others

7 Supportive Care in Oncology Market: Regional Analysis

  • 7.1 Supportive Care in Oncology Regional Market Share Analysis, 2018 & 2026

  • 7.2 Supportive Care in Oncology Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Amgen Inc.

    • 9.1.1 Amgen Inc. Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 APR Applied Pharma Science Research S.A.

    • 9.2.1 APR Applied Pharma Science Research S.A. Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Novartis Ag.

    • 9.3.1 Novartis Ag. Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Hoffmann LA- Roche Ltd

    • 9.4.1 Hoffmann LA- Roche Ltd Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Johnson & Johnson

    • 9.5.1 Johnson & Johnson Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Baxter International Inc

    • 9.6.1 Baxter International Inc Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Teva Pharmaceuticals Industries Ltd

    • 9.7.1 Teva Pharmaceuticals Industries Ltd Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Fagron Group BV

    • 9.8.1 Fagron Group BV Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Acacia Pharma Ltd.

    • 9.9.1 Acacia Pharma Ltd. Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Kyowa Hakko Kirin Co Ltd.

    • 9.10.1 Kyowa Hakko Kirin Co Ltd. Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

 

The List of Tables and Figures (Totals 69 Figures and 157 Tables)

  • Figure Opioid analgesics Supportive Care in Oncology market, 2015 - 2026 (USD Million)

  • Figure Nonsteroidal erythropoietin stimulating agents Supportive Care in Oncology market, 2015 - 2026 (USD Million)

  • Figure Anti-infective drugs Supportive Care in Oncology market, 2015 - 2026 (USD Million)

  • Figure Anti-imflammatory drugs Supportive Care in Oncology market, 2015 - 2026 (USD Million)

  • Figure Bisphosphonates Supportive Care in Oncology market, 2015 - 2026 (USD Million)

  • Figure Monoclonal antibodies Supportive Care in Oncology market, 2015 - 2026 (USD Million)

  • Figure Anti-emetics drugs Supportive Care in Oncology market, 2015 - 2026 (USD Million)

  • Figure Granulocyte colony stimulating factor Supportive Care in Oncology market, 2015 - 2026 (USD Million)

  • Figure Lung cancer market, 2015 - 2026 (USD Million)

  • Figure Prostate cancer market, 2015 - 2026 (USD Million)

  • Figure Breast cancer market, 2015 - 2026 (USD Million)

  • Figure Ovarian cancer market, 2015 - 2026 (USD Million)

  • Figure Leukemia market, 2015 - 2026 (USD Million)

  • Figure Bladder cancer market, 2015 - 2026 (USD Million)

  • Figure Liver cancer market, 2015 - 2026 (USD Million)

  • Figure Melanoma market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Supportive Care in Oncology market, by country, 2015 - 2026 (USD Million)

  • Table North America Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table North America Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table North America Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table Canada Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table Canada Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Europe Supportive Care in Oncology market, by country, 2015 - 2026 (USD Million)

  • Table Europe Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table Europe Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table Europe Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table Germany Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table Germany Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table France Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table France Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table Italy Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table Italy Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table Spain Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table Spain Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Supportive Care in Oncology market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table China Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table China Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table Japan Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table Japan Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table India Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table India Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Supportive Care in Oncology market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table MEA Supportive Care in Oncology market, by country, 2015 - 2026 (USD Million)

  • Table MEA Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table MEA Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table MEA Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Supportive Care in Oncology market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Supportive Care in Oncology market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Supportive Care in Oncology market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Amgen Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table APR Applied Pharma Science Research S.A. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Ag. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hoffmann LA- Roche Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Baxter International Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Teva Pharmaceuticals Industries Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Fagron Group BV Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Acacia Pharma Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Kyowa Hakko Kirin Co Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top